Catalyst Wire Dossier Catalyst Wire Dossier

HUMATIN

paromomycin sulfate · Waylis Therapeutics LLC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HUMATIN, covering 2007-12-14 to 2015-10-28. Get the full timeline:

Most recent: FDA Approved: HUMATIN — Supplemental Application (Waylis Therapeutics LLC)

See pricing